» Articles » PMID: 34916947

DrugHybrid_BS: Using Hybrid Feature Combined With Bagging-SVM to Predict Potentially Druggable Proteins

Overview
Journal Front Pharmacol
Date 2021 Dec 17
PMID 34916947
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Drug targets are biological macromolecules or biomolecule structures capable of specifically binding a therapeutic effect with a particular drug or regulating physiological functions. Due to the important value and role of drug targets in recent years, the prediction of potential drug targets has become a research hotspot. The key to the research and development of modern new drugs is first to identify potential drug targets. In this paper, a new predictor, DrugHybrid_BS, is developed based on hybrid features and Bagging-SVM to identify potentially druggable proteins. This method combines the three features of monoDiKGap (k = 2), cross-covariance, and grouped amino acid composition. It removes redundant features and analyses key features through MRMD and MRMD2.0. The cross-validation results show that 96.9944% of the potentially druggable proteins can be accurately identified, and the accuracy of the independent test set has reached 96.5665%. This all means that DrugHybrid_BS has the potential to become a useful predictive tool for druggable proteins. In addition, the hybrid key features can identify 80.0343% of the potentially druggable proteins combined with Bagging-SVM, which indicates the significance of this part of the features for research.

Citing Articles

Repurposing FDA-Approved Drugs Against Potential Drug Targets Involved in Brain Inflammation Contributing to Alzheimer's Disease.

Sharo C, Zhang J, Zhai T, Bao J, Garcia-Epelboim A, Mamourian E Targets (Basel). 2025; 2(4):446-469.

PMID: 39897171 PMC: 11786951. DOI: 10.3390/targets2040025.


iAmyP: A Multi-view Learning for Amyloidogenic Hexapeptides Identification Based on Sequence Least Squares Programming.

Cai J, Zhao J, Bin Y, Xia J, Zheng C Interdiscip Sci. 2024; .

PMID: 39546159 DOI: 10.1007/s12539-024-00666-3.


DPI_CDF: druggable protein identifier using cascade deep forest.

Arif M, Fang G, Ghulam A, Musleh S, Alam T BMC Bioinformatics. 2024; 25(1):145.

PMID: 38580921 PMC: 11334562. DOI: 10.1186/s12859-024-05744-3.


Empirical comparison and analysis of machine learning-based approaches for druggable protein identification.

Shoombuatong W, Schaduangrat N, Nikom J EXCLI J. 2023; 22:915-927.

PMID: 37780939 PMC: 10539545. DOI: 10.17179/excli2023-6410.


PINNED: identifying characteristics of druggable human proteins using an interpretable neural network.

Cunningham M, Pins D, Dezso Z, Torrent M, Vasanthakumar A, Pandey A J Cheminform. 2023; 15(1):64.

PMID: 37468968 PMC: 10354961. DOI: 10.1186/s13321-023-00735-7.


References
1.
Zheng L, Huang S, Mu N, Zhang H, Zhang J, Chang Y . RAACBook: a web server of reduced amino acid alphabet for sequence-dependent inference by using Chou's five-step rule. Database (Oxford). 2019; 2019. PMC: 6893003. DOI: 10.1093/database/baz131. View

2.
Russ A, Lampel S . The druggable genome: an update. Drug Discov Today. 2005; 10(23-24):1607-10. DOI: 10.1016/S1359-6446(05)03666-4. View

3.
Zhu Y, Li F, Xiang D, Akutsu T, Song J, Jia C . Computational identification of eukaryotic promoters based on cascaded deep capsule neural networks. Brief Bioinform. 2020; 22(4). PMC: 8522485. DOI: 10.1093/bib/bbaa299. View

4.
Ding Y, Tang J, Guo F . Identification of Drug-Side Effect Association via Semisupervised Model and Multiple Kernel Learning. IEEE J Biomed Health Inform. 2018; 23(6):2619-2632. DOI: 10.1109/JBHI.2018.2883834. View

5.
Jamali A, Ferdousi R, Razzaghi S, Li J, Safdari R, Ebrahimie E . DrugMiner: comparative analysis of machine learning algorithms for prediction of potential druggable proteins. Drug Discov Today. 2016; 21(5):718-24. DOI: 10.1016/j.drudis.2016.01.007. View